Product delay hits Cedara profits

Article

A product roll-out delay is the reason Cedara Software gave for its disappointing third quarter 2000 profits. The company's net loss was $119,000 (Canadian), compared to net income of $385,000 in the third quarter of 1999. Revenue for third

A product roll-out delay is the reason Cedara Software gave for its disappointing third quarter 2000 profits. The company's net loss was $119,000 (Canadian), compared to net income of $385,000 in the third quarter of 1999. Revenue for third quarter 2000 was $15.9 million, compared to $12.3 million for the same period a year earlier.

A new platform, the SNN 3.0, which integrates multiple surgical software systems, was not shipped to installed base customers until March 31, and was launched on the market immediately thereafter.

Cedara makes software for diagnostic imaging, image management, image-guided therapy, and cardiology. It recently released both Internet streaming software for medical imaging, called Cedara directDICOM, and Image Management Business for the PACS market.

Another factor affecting Cedara's earnings, according to a company statement, was losses for Surgical Navigation Specialists, in which Cedara has a minority interest. The company believes it will recover this loss from SNS profits in future quarters.

Cedara chairman and CEO Michael Greenberg said in a statement, "We have a backlog of orders for the SNN 3.0 platform. Despite the delay in shipping surgical systems, our R&D investment in growth markets is showing its potential."

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.